Air Canada
AC
GoldMining Inc
GOLD
DeFi Technologies Inc
DEFI
4
Realbotix Corp
XBOT
5
Palantir Technologies Inc
PLTR
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 3.540
- -0.050-1.39%
15min DelayMarket Closed May 9 16:00 ET
251.30MMarket Cap-9.83P/E (TTM)
3.570High3.500Low40.66KVolume3.560Open3.590Pre Close144.12KTurnover3.75052wk High0.07%Turnover Ratio70.99MShares1.65052wk Low-0.36EPS TTM208.88MFloat Cap3.980Historical HighLossP/E (Static)59.01MShs Float0.800Historical Low-0.36EPS LYR1.95%Amplitude--Dividend TTM98.33P/B1Lot Size--Div YieldTTM
NervGen Pharma Corp Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -49.09%-16.84M | -18.58%-3.66M | -302.52%-5.75M | -109.18%-4.18M | 32.09%-3.25M | 36.49%-11.3M | 38.93%-3.09M | 70.28%-1.43M | 45.90%-2M | -13.11%-4.78M |
| Net income from continuing operations | -7.25%-24.01M | -0.00%-8.61M | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M |
| Operating gains losses | -91.47%437.15K | -33.65%2.52M | -263.26%-1.67M | 1,201.29%1.86M | -1,483.48%-2.27M | 297.34%5.12M | 628.50%3.79M | 153.44%1.02M | 285.75%142.6K | 4,273.79%164.03K |
| Depreciation and amortization | -42.21%83.8K | -59.06%15.81K | -60.00%14.65K | -57.06%15.03K | 10.22%38.31K | 25.96%145K | 11.13%38.62K | 5.39%36.63K | 2.27%35K | 205.29%34.75K |
| Remuneration paid in stock | -4.12%5.8M | 20.10%1.67M | -7.57%1.62M | -37.49%1.35M | 56.28%1.15M | 117.83%6.04M | 159.18%1.39M | 187.55%1.75M | 160.24%2.16M | -7.57%736.78K |
| Other non cashItems | -33.22%9.79K | -100.03%-1 | -99.97%1 | 81.35%6.94K | -31.37%2.85K | -97.23%14.66K | -28.72%3.18K | -99.32%3.51K | --3.83K | --4.15K |
| Change In working capital | 448.89%838.56K | 153.22%743.29K | -936.03%-495.15K | -0.84%415.56K | 117.27%174.85K | -111.36%-240.35K | -71.45%293.54K | 110.47%59.23K | -75.59%419.1K | -1,473.59%-1.01M |
| -Change in receivables | 26.03%-165.09K | -80.21%-408.86K | -69.54%5.11K | -95.95%2.03K | 474.63%236.63K | -703.60%-223.18K | -43,531.54%-226.88K | -76.13%16.78K | 285.95%50.08K | -975.86%-63.16K |
| -Change in prepaid assets | -490.31%-223.74K | -105.34%-9.73K | -3.29%-164.92K | 136.12%121.77K | -145.94%-170.85K | 123.65%57.32K | 166.31%182.21K | -407.73%-159.67K | -519.63%-337.15K | 472.82%371.94K |
| -Change in payables and accrued expense | 1,747.76%1.23M | 243.54%1.16M | -265.92%-335.34K | -58.68%291.77K | 108.26%109.07K | -103.21%-74.49K | -74.05%338.21K | 129.39%202.12K | -57.54%706.17K | -3,297.88%-1.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -49.09%-16.84M | -18.58%-3.66M | -302.52%-5.75M | -109.18%-4.18M | 32.09%-3.25M | 36.49%-11.3M | 38.93%-3.09M | 70.28%-1.43M | 45.90%-2M | -13.11%-4.78M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 142.40%58.87K | 2,523,100.00%25.23K | 118.22%25.23K | 385.70%8.41K | 0 | -557.92%-138.85K | 1 | -2,320.19%-138.46K | 70.54%-2.94K | 147.27%2.55K |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | 85.43%-3.07K | --1 | 53.17%-2.68K | 70.54%-2.94K | 147.27%2.55K |
| Net intangibles purchas and sale | 143.36%58.87K | --25.23K | --25.23K | ---- | ---- | ---135.78K | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 142.40%58.87K | 2,523,100.00%25.23K | 118.22%25.23K | 385.70%8.41K | --0 | -557.92%-138.85K | --1 | -2,320.19%-138.46K | 70.54%-2.94K | 147.27%2.55K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,861.71%22.7M | 314.61%310K | 272.66%269.74K | -56.17%111.28K | 5,924.01%22M | -96.62%766.29K | -6.16%74.77K | -99.64%72.38K | -90.09%253.86K | 184.63%365.27K |
| Net issuance payments of debt | 0.00%-100.93K | 0.00%-25.23K | 0.00%-25.23K | 0.00%-25.23K | 0.00%-25.23K | -33.33%-100.93K | 0.00%-25.23K | -0.00%-25.23K | 0.00%-25.23K | ---25.23K |
| Net common stock issuance | --23.01M | --0 | --0 | --0 | --23.01M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 63.12%1.41M | 235.23%335.23K | 202.16%294.95K | -41.26%163.95K | 58.89%620.46K | -71.87%867.21K | -20.38%100K | -58.51%97.61K | -89.24%279.09K | 204.29%390.51K |
| Net other financing activities | ---1.63M | --0 | --19 | ---27.44K | ---1.6M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,861.71%22.7M | 314.61%310K | 272.66%269.74K | -56.17%111.28K | 5,924.01%22M | -96.62%766.29K | -6.16%74.77K | -99.64%72.38K | -90.09%253.86K | 184.63%365.27K |
| Net cash flow | ||||||||||
| Beginning cash position | -48.07%11.66M | 42.09%21.01M | 65.15%26.56M | 68.15%30.3M | -48.07%11.66M | 32.62%22.45M | -46.62%14.79M | 38.06%16.08M | 40.48%18.02M | 32.62%22.45M |
| Current changes in cash | 155.43%5.91M | -10.40%-3.32M | -265.01%-5.46M | -132.37%-4.06M | 524.97%18.76M | -320.59%-10.67M | 39.46%-3.01M | -109.93%-1.5M | -53.06%-1.75M | -7.54%-4.41M |
| Effect of exchange rate changes | -146.19%-305.01K | -263.24%-416.19K | -147.23%-93.56K | 266.02%317.11K | -585.85%-112.37K | -118.04%-123.89K | 58.18%-114.58K | -80.06%198.07K | -416.69%-191K | -516.90%-16.38K |
| End cash Position | 48.10%17.27M | 48.10%17.27M | 42.09%21.01M | 65.15%26.56M | 68.15%30.3M | -48.07%11.66M | -48.07%11.66M | -46.62%14.79M | 38.06%16.08M | 40.48%18.02M |
| Free cash from | -47.25%-16.84M | -18.58%-3.66M | -266.97%-5.75M | -108.88%-4.18M | 32.09%-3.25M | 35.77%-11.44M | 38.93%-3.09M | 67.44%-1.57M | 45.97%-2M | -12.97%-4.78M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.